Eli Lilly (LLY): FY24 Q4 earnings call, Feb 6, 2025

Thu, Feb 6Earnings callSpeaker-labelled transcriptEli Lilly

No Kalshi or Polymarket word markets were listed for Eli Lilly’s Feb 6, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “Impact”; 3 quoted, at least 25 words apart.

Terence Flynnanalystqa

…your expectations for Zepbound payer dynamics and access this year, particularly the impact from the OSA label. I know you've also filed for heart failure…

James Shinanalystqa

…titration schedule. But can you go over how this titration schedule may impact the Phase II weight loss, A1c and safety results published in Lancet…

David Risingeranalystqa

…quite catch that. If you could just provide some more color and quantify the potential impact on the opportunity for script trends following that occurring.

Agents: this page as TSV at /api/v1/appearances/eli-lilly:2025-02-06:earnings_call · words: /api/v1/brief?appearance=eli-lilly:2025-02-06:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP